OPC-167832, a Novel Carbostyril Derivative with Potent Antituberculosis Activity as a DprE1 Inhibitor

There is an urgent need for new, potent antituberculosis (anti-TB) drugs with novel mechanisms of action that can be included in new regimens to shorten the treatment period for TB. After screening a library of carbostyrils, we optimized 3,4-dihydrocarbostyril derivatives and identified OPC-167832 a...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Antimicrob Agents Chemother
Main Authors: Hariguchi, Norimitsu, Chen, Xiuhao, Hayashi, Yohei, Kawano, Yoshikazu, Fujiwara, Mamoru, Matsuba, Miki, Shimizu, Hiroshi, Ohba, Yoshio, Nakamura, Izuru, Kitamoto, Ryuki, Shinohara, Toshio, Uematsu, Yukitaka, Ishikawa, Shunpei, Itotani, Motohiro, Haraguchi, Yoshikazu, Takemura, Isao, Matsumoto, Makoto
Formato: Artigo
Idioma:Inglês
Publicado em: American Society for Microbiology 2020
Assuntos:
Pharmacology
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC7269503/
https://ncbi.nlm.nih.gov/pubmed/32229496
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1128/AAC.02020-19
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados